Real-world data confirms the efficacy of dolutegravir-based dual therapy
More than six years of real-world data collected from people living with HIV switching to dolutegravir-based two-drug regimens confirm comparable efficacy to three-drug regimens, consistent with previous clinical trial results. Dr Conor Bowman and colleagues at the Royal Free Hospital have published these findings in the journal AIDS. Analyzing retrospective patient data from a London … Read more